Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jun 14;361(9374):2045-6.
doi: 10.1016/s0140-6736(03)13615-x.

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

J Cinatl  1 , B Morgenstern, G Bauer, P Chandra, H Rabenau, H W Doerr
Affiliations

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

J Cinatl et al. Lancet. .

Abstract

The outbreak of SARS warrants the search for antiviral compounds to treat the disease. At present, no specific treatment has been identified for SARS-associated coronavirus infection. We assessed the antiviral potential of ribavirin, 6-azauridine, pyrazofurin, mycophenolic acid, and glycyrrhizin against two clinical isolates of coronavirus (FFM-1 and FFM-2) from patients with SARS admitted to the clinical centre of Frankfurt University, Germany. Of all the compounds, glycyrrhizin was the most active in inhibiting replication of the SARS-associated virus. Our findings suggest that glycyrrhizin should be assessed for treatment of SARS.

PubMed Disclaimer

Figures

Figure
Figure
Effect of glycyrrhizin on replication of SARS-associated coronavirus in Vero cells Cells were fixed with 60 parts methanol to 40 parts acetone 72 h after infection. Virus was detected in serum from the patient with SARS by peroxidase staining. (A) mock infected cells. (B) infected cells without treatment. (C) infected cells treated with 4000 mg/L glycyrrhizin. (D) infected cells treated with 1000 mg/L glycyrrhizin.
See this image and copyright information in PMC

References

    1. Drosten C, Gunther S, Preiser W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967–1976. - PubMed
    1. Crance JM, Scaramozzino N, Jouan A, Garin D. Interferon, ribavirin, 6-azauridine, and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res. 2003;58:73–79. - PubMed
    1. Jeong HG, Kim JY. Induction of inducible nitric oxide synthase expression by 18β-glycyrrhetinic acid in macrophages. FEBS Lett. 2002;513:208–212. - PubMed
    1. Lin YL, Huang YL, Ma SH. Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol. 1997;71:5227–5235. - PMC - PubMed
    1. Booth CM, Matukas LM, Tomlinson GA. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:1–9. - PubMed